T-cell prolymphocytic leukemia: an aggressive T cell malignancy with frequent cutaneous tropism.
BACKGROUND
T-cell prolymphocytic leukemia (T-PLL), formerly categorized as T-cell chronic lymphocytic leukemia, is a rare and aggressive hematologic malignancy. Although the skin is characteristically involved, it is not a well-recognized entity in the dermatologic literature.


METHODS
Six cases of cutaneous T-PLL are presented from a clinical, light microscopic, and phenotypic perspective.


RESULTS
The patient population comprised 2 women and 4 men, with a mean age of 69.8 years. The disease was associated in all with skin involvement with facial preference; edema, purpura, and lesional symmetry were characteristic. The skin biopsies demonstrated a largely non-epidermotropic angiocentric lymphocytic infiltrate with accompanying hemorrhage. The cells showed irregular- to reniform-shaped nuclei with small nucleoli and eosinophilic rims of cytoplasm. Phenotypic studies revealed three prevailing profiles: CD4 dominant in 4, CD8 dominant in one, and co-expression of CD4 and CD8 in one. CD3 loss was seen in one case. All expressed T-cell leukemia 1 (TCL-1) and CD7; cutaneous lymphocyte antigen expression was discernible in a dot-like perinuclear array. All cases tested excluding one expressed TCL-1 and CD52. In two cases tested, T-cell receptor beta rearrangements were observed. Cytogenetic studies demonstrated a paracentromeric chromosome 14 inversion. Polysomy 8 and MYC amplification was seen in one case, manifesting an aggressive clinical course. Four patients died from their disease within 18 months of diagnosis.


CONCLUSIONS
Cytogenetic MYC amplification, FISH, and TCR beta studies were conducted on each of 2 cases, respectively, due to limitations of tissue block samples and/or peripheral blood. cMYC translocation studies were conducted on 3 of the 6 cases, again due to limitations imposed by the tissue samples on the cases. The last case was recently diagnosed and, therefore, long-term follow-up is not possible.


CONCLUSIONS
T-PLL is a distinctive post-thymic T-cell malignancy with frequent cutaneous tropism. A diagnosis is possible in almost all cases based on characteristic clinical, light microscopic, phenotypic, and cytogenetic features. While a chromosome 14 inversion is highly characteristic, additional inherent cytogenetic differences, such as trisomy 8 with CMYC over-amplification, may account for some case to case variation in clinical course.
Magro
Cynthia M
CM
Department of Pathology, The Ohio State University, Columbus, Ohio, USA.
Morrison
Carl D
CD
Heerema
Nyla
N
Porcu
Pierluigi
P
Sroa
Novie
N
Deng
April C
AC
D000368:Aged; D000369:Aged, 80 and over; D000782:Aneuploidy; D015703:Antigens, CD / Q000378:metabolism; D000951:Antigens, Neoplasm / Q000378:metabolism; D015496:CD4-Positive T-Lymphocytes / Q000473:pathology; D000074301:CD52 Antigen; D018414:CD8-Positive T-Lymphocytes / Q000473:pathology; D020732:Cytogenetic Analysis; D005145:Face; D005260:Female; D005784:Gene Amplification; D015321:Gene Rearrangement; D006023:Glycoproteins / Q000378:metabolism; D006801:Humans; D017404:In Situ Hybridization, Fluorescence; D015463:Leukemia, Prolymphocytic / Q000235:genetics / Q000378:metabolism / Q000401:mortality / Q000473:pathology*; D015461:Leukemia, Prolymphocytic, T-Cell / Q000235:genetics / Q000378:metabolism / Q000401:mortality / Q000473:pathology*; D008297:Male; D008875:Middle Aged; D010641:Phenotype; D011518:Proto-Oncogene Proteins / Q000378:metabolism; D016271:Proto-Oncogene Proteins c-myc / Q000235:genetics; D016693:Receptors, Antigen, T-Cell, alpha-beta / Q000235:genetics; D012867:Skin / Q000473:pathology*
D015703:Antigens, CD; D000951:Antigens, Neoplasm; D000074301:CD52 Antigen; C000613862:CD52 protein, human; D006023:Glycoproteins; C489427:MYC protein, human; D011518:Proto-Oncogene Proteins; D016271:Proto-Oncogene Proteins c-myc; D016693:Receptors, Antigen, T-Cell, alpha-beta; C090851:TCL1A protein, human